Detalles de la búsqueda
1.
Identifying the safety profile of a novel infectivity-enhanced conditionally replicative adenovirus, Ad5-delta24-RGD, in anticipation of a phase I trial for recurrent ovarian cancer.
Am J Obstet Gynecol
; 196(4): 389.e1-9; discussion 389.e9-10, 2007 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-17403430
2.
Identifying the safety profile of Ad5.SSTR/TK.RGD, a novel infectivity-enhanced bicistronic adenovirus, in anticipation of a phase I clinical trial in patients with recurrent ovarian cancer.
Clin Cancer Res
; 15(12): 4131-7, 2009 Jun 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19509153
Resultados
1 -
2
de 2
1
Próxima >
>>